Editor's Note According to results from a randomized trial, titled KEYNOTE-689, adding pembrolizumab (Keytruda) to surgery and standard adjuvant therapy significantly prolongs event-free survival (EFS) in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC), MedPage Today April 28 reports. Experts are calling the findings a major…
Editor's Note Same-day discharge following catheter ablation is both safe and increasingly standard in appropriately selected patients, according to a new joint scientific statement from the Heart Rhythm Society and the American College of Cardiology, TCTMD April 24 reports. The statement reflects growing evidence and clinical experience suggesting that, with…
Editor's Note Ambulatory surgery center (ASC) leaders elevate safety by treating patient selection as a clinical gatekeeper, then prop that rigor with data-driven workflows, advanced monitoring, and targeted robotics to bring complex spine cases safely into the outpatient space. An interview with Glenn Snyders Jr, MD, medical director and head…
Editor's Note A large-scale study of over 50,000 ambulatory surgery center (ASC) procedures shows a strikingly low rate of 24-hour unplanned postoperative hospital admissions, offering a benchmark that other ASCs can strive to match, General Surgery News March 26 reports. Over a 7-year period from 2016 to 2022, researchers at…
Editor's Note As joint replacement (JR) procedures increasingly move from the hospital setting to ambulatory surgical centers (ASCs), selecting the right candidates for these outpatient procedures becomes crucial. To support this transition, study authors Madhav Chowdhry, MD, and Edward J. McPherson, MD, developed a comprehensive, evidence-based checklist called Checklist Outpatient-Joint…